Call Us + 33 1 84 88 31 00

Call Us + 33 1 84 88 31 00

Home | French Legislation Articles | French Public Health Code | Regulatory part | Part One: General health protection | Book II: Donation and use of human body parts and products | Title II: Human blood | Chapter I: Collection, preparation and storage of blood, blood components and labile blood products | Section 2: Biological qualification of blood donations | Subsection 2: Biological analyses and screening tests. | Article D1221-7 of the French Public Health Code

French Public Health Code
- Regulatory part
  - Part One: General health protection
    - Book II: Donation and use of human body parts and products
      - Title II: Human blood
        Chapter I: Collection, preparation and storage of blood, blood components and labile blood products
        Section 2: Biological qualification of blood donations
        Subsection 2: Biological analyses and screening tests.

Article D1221-7 of the French Public Health Code

Article D1221-7 of the French Public Health Code

November 5, 2023
9:30 pm

Blood or its components may only be used to prepare labile blood products intended for direct therapeutic use if the results of the screening tests provided for in 5° of article D. 1221-6 are negative.

Original in French 🇫🇷

Article D1221-7

Le sang ou ses composants ne peuvent être utilisés en vue de préparer des produits sanguins labiles destinés à un usage thérapeutique direct que si les résultats des tests de dépistage prévus au 5° de l’article D. 1221-6 sont négatifs.

Need help with this article? Get help from a French lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.